re-acceler growth
increas forecast earn increas target price
upgrad rate outperform neutral
believ market sentiment becom overli pessimist follow weaker
organ growth result forecast acceler organ
growth driven market share gain oil price remain
elev product launch household bioag weaker
comp ag feed forecast organ growth remaind
year rise thereaft believ increas confid
return growth re-rat share toward histor averag pe
share household bioenergi bioag link commod
price see link oil sustain higher believ
novozym yield enhanc product start gain market share
low yield/chem altern histor month lag
estim oil sustain drive growth
base busi upsid new product launch
new product launch novozym begin launch new hygien
product household higher yield corn inocul bioag
believ product plu number recent launch
contribut growth late year add group organ growth
valuat risk novozym target price dkr
round averag pe multipl ev/ebitda multipl
dcf valuat key risk outperform rate
continu weak bioag lack uptak recent product launch
valuat metric
price month
neutral outperform
price rel chart measur perform
omxc close
spot exchang rate
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
novozym a/ denmark-bas biotechnolog compani
engag product sale industri enzym
busi consist two segment enzym busi segment
price may rate neutral outperform target price analyst mathew
profit tax
associ
chang work capit
cash non-cash item
flow oper
free cash-flow firm
flow invest
issuanc retir debt
cash-flow financ
chang net cash/debt
return peak oil would gener organ growth
could justifi novozym rerat toward histor pe premium
net debt start
chang net debt
net debt end
total equiti liabil
share wtd average mn
ratio valuat
net debt ebitda
return trough oil would gener organ growth could
justifi novozym derat toward low end histor pe
trade
price rel chart measur perform omxc
close
spot exchang rate
figur nvz organ growth lag oil price
quarter organ growth drive rel pe
figur nvz pe vs peer de-coupl
oil price sinc late oil price led growth yet
come
figur regress analysi organ growth suggest spot oil/corn/soy drive core
organ growth led household energi estim upcom project launch support
organ per annum
bioag feed
make minor chang forecast ebit forecast
increas organ growth
respect function easier compar feed pharma
support product launch hygien household new
strain corn innocul ag feed
forecast organ growth fy low end compani
mid-term forecast organ growth flat adjust margin
credit suiss ahead consensu next year
figur chang forecast
increas novozym target price
round averag pe ev/ebitda peer multipl dcf
flavour fragranc givaudan symris sensient sell tast scent
product similar consum market gener slightli lower organ growth
christian hansen sell cultur probiot consum market
histor gener consist higher growth/return vs novozym
pe valuat appli price-to-earnings multipl novozym ep
price-to-earnings ep take evenli weight averag yield
valuat multipl repres premium basket peer
repres fair valu base rel organ growth perform view
figur
ev/ebitda valuat appli ev/ebitda multipl novozym
ebitda ev/ebitda multipl ebitda
evenli weight averag yield valuat multipl
premium basket peer repres fair valu base rel growth
perform view figur
figur peer price-to-earnings ev/ebitda multipl
re-rat share toward histor averag
expect re-rat share toward
dcf valu novozym dkr base follow assumpt
explicit forecast year ebit growth driven top-line expans
adjust ebit margin flat
period year ebit margin growth
termin period ebit margin growth per annum flex
termin period assumpt margin
ebitda margin yield warrant price sensit
wacc base beta equiti risk premium target gear
nd/ev
share
less increase/add decreas wc
free cash-flow firm fcff
cumul factor period
discount factor start first forecast period
equiti
debt
averag spread risk-fre rate
pre-tax cost debt
averag corpor tax rate compani
post-tax cost debt
number year explicit estim
year start termin period
figur dcf sensit termin period assumpt
warrant price sensit termin
growth rate margin
opportun return high singl growth
review underli core opportun exist busi overlay growth
opportun ongoing/new product launch believ spot oil/corn/soy
core novozym busi grow success execut new
product pipelin add anoth growth per annum medium term
summaris growth avenu follow
growth believ underli busi correl commod
price indirect relationship wherebi higher commod price typic
favour novozym market share/pr favour use high yield/high
perform enzym regress base model suggest oil novozym
core grow organ
hygien novozym ramp rang hygien enzym wash powder
acceler first product type market
enabl erad odour caus bacteria degre wash
corn innocul novozym start deliv corn inocul bacteria partner
monsanto sale product ramp
introduct acceleron higher yield strain increas
valu share novozym bioag allianc
probiot novozym develop launch probiot poultri
farm product bacterium grow gastrointestin tract
anim prevent harm bacteria colon gut increas yield
yeast ethanol novozym roll rang high perform yeast
ethanol produc reduc ferment time
palm oil process novozym launch enzym rang
improv yield palm oil process
cellulos add revenu ethanol trial industri plant ramp
oper rate come year howev continu believ industri
becom materi oil price sub given neg irr ex subsidi
yeast
mid-term revenu opportun new
yeast ethanol
cumult growth opportun
annualis growth opportun
contribut
contribut group
growth oil
use regress analysi estim underli growth rate
sustain household energi ag feed spot trough peak
commod price scenario regress organ growth commod price estim
sensit novozym organ growth commod price specif highlight
household strong correl oil price organ
growth houshold due enzym compet market share
chemical/oil base surfact oil price increas chemic price
move custom formul greater amount enzym product
energi show strong correl oil price divid corn price
relat ethanol crush spread high ethanol/oil price lower corn price
mean better margin ethanol produc result custom upgrad higher
bioag feed growth correl averag corn soy price higher soft
commod price mean crop farmer make better profit therefor
will tri biolog product livestock farmer will use
yield enhanc biolog reduc anim food consumpt
aggreg output regress model commod price
environ spot price model estim sustain organ growth
novozym core busi use long term averag growth food bev
figur output regress model base trough
model calulc organ growth base
establish novozym abl grow spot
commod price persist overlay new product launch contribut growth
estim novozym could reach organ growth
contribut new product launch next year
estim pipelin new product launch could add around cumul
organ growth next year per annum
review individu opportun follow section report
figur growth plu organ growth support organ
growth per annum spot commod price
bioag feed
figur major product launch ramp next year
mid-term revenu opportun new
yeast ethanol
cumult growth opportun
annualis growth opportun
contribut
contribut group
novozym launch new rang hygien enzym one major
custom roll wider rang broader market first materi sale
expect product enzym help elimin odour caus
bacteria wash low temperatur believ rang highli
success given product kind market enabl key claim
wash powder maker estim contribut household
cumul contribut group roll
come year assum
current averag enzym use wash powder europ us
includ proteas amalas remov protein starch stain
carbohydras remov thicken silanas pectin remov lipas remov
ingredi plu select cellulos
assum penetr custom hygien enzym
averag price point in-line current enzym addit creat
opportun household volum opportun custom
figur novozym opportun hygien
nvz hygien opportun household
averag enzym wash powder
revenu household
penetr custom
contribut household
contribut group
bioag opportun corn
bioag feed novozym launch corn inocul partner monsanto
first corn inocul market improv yield corn
farmer allianc launch improv strain
market grow season new strain increas
yield allow allianc charg higher valu add
farmer estim drive contribut high
singl digit contribut premis upon
state yield benefit success give overal yield benefit
corn equat benefit
attribut allianc novozym share farmer
estim allianc sell acr acr
target monsanto corn acr next year
figur valu opportun corn soy bioag
probabl success
benefit farmer
valu share bioag allianc farmer
valu farmer
valu allianc
charl martineau pm univers toronto figur revenu opportun corn innocul
revenu opportun corn busi
penetr corn acr
organ growth contribut ag feed year
organ growth contribut group year
novozym roll number new product bioenergi name
cellulos enzym use convert cellulos wast plant materi rather
starch foodstuff ethanol market potenti larg
novozym enzym worth valu ethanol enzym howev
add revenu ramp exist trial plant believ
econom add current oil price specif estim total
contribut group base novozym serv total plant
potenti capac gal/yr estim oper rate current
move come year product process refin
creat gal/yr revenu opportun
nvz opportun cellulos ethanol bioenergi
upsid volum
contribut bioenergi
contribut group
yeast ethanol novozym launch yeast platform ethanol
product compani current sell enzym support ethanol product
first time compani move yeast convert starch
ethanol product claim reduc ethanol product time hour vs
compet product estim product could drive growth
next year energi improv product speed would add
crush spread ethanol price minu corn cost equat
valu add would go novozym plu basic sell price
novozym penetr us ethanol market
next year add cumul revenu energi divis
charl martineau pm univers toronto figur novozym yeast ethanol opportun
nvz opportun yeast ethanol
market revenu basic yeast
averag price yeast
improv product time
price ethanol
corn/gallon
valu ethanol crusher
valu novozym
potenti contribut bioenergi
potenti contribut group
ethanol blend mandat georg bush senior
blend restrict creat mid-term upsid bioenergi
strong period ethanol product growth follow introduct
ethanol
production/consumpt stall last year initi due
blend wall ethanol allow blend gasolin
howev waiv epa vehicl built waiv
vehicl built distribut restrict june-sept
year due vapour pressur regul howev
sinc moder growth ethanol consumpt us
blend rate gone absolut ethanol
product increas per annum move higher blend
limit vehicl warrante issu lack pump infrastructur consum confus
trump administr process lift summer restrict sell
blend support instal pump current
number total ga pump us ga retail previous
unwil chang pump twice year due restrict
eas
therefor believ also upsid ethanol product us mid-
term higher ethanol blend becom preval though take time given
limit dispens infrastructur
ag feed probiot opportun
novozym develop launch probiot poultri farm product
bacterium grow gastrointestin tract anim prevent harm
bacteria colon gut increas yield estim product
potenti add revenu group base upon
total poultri market us/europ worth ad yield benefit
probiot assum novozym penetr market near
term ad valu total attribut
could add revenu growth ag feed group
nvz opportun probiot ag feed
rate growth improv due probiot
uptak probiot
contribut ag feed
contribut group
ag feed palm oil process
novozym launch enzym assist palm oil process product
palmora enzym break cell wall palm fruit help releas
oil state yield benefit
total pal oil market usd assum uptak add
valu novozym take
could add revenu food beverag divis
nvz opportun palm oil process
uptak palmora
contribut food bev
contribut group
compani mention price
